About: Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. As of May 18, 2026, Soleno Therapeutics, Inc. operates as a subsidiary of Neurocrine Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $53.01 (+0.04%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
SLNO NASDAQ Soleno Therapeutics Inc
Soleno Therapeutics Inc share price
Atividade de preço de SLNO
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
SLNO price performance
quote.marketSignals